+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Implantable Cardioverter Defibrillators Market Research Report by Implantation Location, Product, End User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • PDF Icon

    Report

  • 123 Pages
  • January 2023
  • Region: United States
  • 360iResearch™
  • ID: 5722150
The United States Implantable Cardioverter Defibrillators Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Implantable Cardioverter Defibrillators Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Implantable Cardioverter Defibrillators Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Implantable Cardioverter Defibrillators Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Implantable Cardioverter Defibrillators Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Implantable Cardioverter Defibrillators Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Implantable Cardioverter Defibrillators Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Implantation Location, the market is studied across Subcutaneous Implantable Cardioverter Defibrillator and Transvenous Implantable Cardioverter Defibrillator.
  • Based on Product, the market is studied across Biventricular/Cardiac Resynchronization Therapy Defibrillators, Dual-Chamber ICD, and Single-Chamber ICD.
  • Based on End User, the market is studied across Cardiac Center, Hospital & Clinic, Ambulatory Care Unit, Electrophysiology Laboratory, and Home Care Setting.
  • Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Implantable Cardioverter Defibrillators Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Implantable Cardioverter Defibrillators Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Implantable Cardioverter Defibrillators Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Implantable Cardioverter Defibrillators Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Implantable Cardioverter Defibrillators Market, including Abbott Laboratories, AtaCor Medical, Inc., BIOTRONIK SE & Co KG, Boston Scientific Corporation, Koninklijke Philips N.V., LivaNova plc, Medtronic plc, and MicroPort Scientific Corporation.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Implantable Cardioverter Defibrillators Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Implantable Cardioverter Defibrillators Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Implantable Cardioverter Defibrillators Market?
4. What is the competitive strategic window for opportunities in the United States Implantable Cardioverter Defibrillators Market?
5. What are the technology trends and regulatory frameworks in the United States Implantable Cardioverter Defibrillators Market?
6. What is the market share of the leading vendors in the United States Implantable Cardioverter Defibrillators Market?
7. What modes and strategic moves are considered suitable for entering the United States Implantable Cardioverter Defibrillators Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of cardiac diseases in the U.S.
5.1.1.2. Increasing number of training and awareness programs for ICDs
5.1.2. Restraints
5.1.2.1. Incidences of product recall
5.1.3. Opportunities
5.1.3.1. Integration of advanced technologies in ICDs
5.1.4. Challenges
5.1.4.1. Risks associated with ICDs
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Implantable Cardioverter Defibrillators Market, by Implantation Location
6.1. Introduction
6.2. Subcutaneous Implantable Cardioverter Defibrillator
6.3. Transvenous Implantable Cardioverter Defibrillator

7. Implantable Cardioverter Defibrillators Market, by Product
7.1. Introduction
7.2. Biventricular/Cardiac Resynchronization Therapy Defibrillators
7.3. Dual-Chamber ICD
7.4. Single-Chamber ICD

8. Implantable Cardioverter Defibrillators Market, by End User
8.1. Introduction
8.2. Cardiac Center
8.3. Hospital & Clinic
8.4. Ambulatory Care Unit
8.5. Electrophysiology Laboratory
8.6. Home Care Setting

9. California Implantable Cardioverter Defibrillators Market
9.1. Introduction

10. Florida Implantable Cardioverter Defibrillators Market
10.1. Introduction

11. Illinois Implantable Cardioverter Defibrillators Market
11.1. Introduction

12. New York Implantable Cardioverter Defibrillators Market
12.1. Introduction

13. Ohio Implantable Cardioverter Defibrillators Market
13.1. Introduction

14. Pennsylvania Implantable Cardioverter Defibrillators Market
14.1. Introduction

15. Texas Implantable Cardioverter Defibrillators Market
15.1. Introduction

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Product Portfolio Analysis, By Key Player
16.5. Competitive Scenario
16.5.1. Merger & Acquisition
16.5.2. Agreement, Collaboration, & Partnership
16.5.3. New Product Launch & Enhancement
16.5.4. Investment & Funding
16.5.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Abbott Laboratories
17.2. AtaCor Medical, Inc.
17.3. BIOTRONIK SE & Co KG
17.4. Boston Scientific Corporation
17.5. Koninklijke Philips N.V.
17.6. LivaNova plc
17.7. Medtronic plc
17.8. MicroPort Scientific Corporation

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET DYNAMICS
FIGURE 8. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET COMPETITIVE STRATEGIC WINDOW, BY IMPLANTATION LOCATION, 2030
FIGURE 12. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 15. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 17. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY BIVENTRICULAR/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DUAL-CHAMBER ICD, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SINGLE-CHAMBER ICD, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 21. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2030
FIGURE 23. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CENTER, 2018-2030 (USD MILLION)
FIGURE 24. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITAL & CLINIC, 2018-2030 (USD MILLION)
FIGURE 25. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY CARE UNIT, 2018-2030 (USD MILLION)
FIGURE 26. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY ELECTROPHYSIOLOGY LABORATORY, 2018-2030 (USD MILLION)
FIGURE 27. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOME CARE SETTING, 2018-2030 (USD MILLION)
FIGURE 28. CALIFORNIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 29. FLORIDA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 30. ILLINOIS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 31. NEW YORK IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 32. OHIO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 33. PENNSYLVANIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 34. TEXAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 35. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 36. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 37. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY BIVENTRICULAR/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY BIVENTRICULAR/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS, BY STATE, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DUAL-CHAMBER ICD, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DUAL-CHAMBER ICD, BY STATE, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SINGLE-CHAMBER ICD, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SINGLE-CHAMBER ICD, BY STATE, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CENTER, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CENTER, BY STATE, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITAL & CLINIC, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITAL & CLINIC, BY STATE, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY CARE UNIT, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY CARE UNIT, BY STATE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY ELECTROPHYSIOLOGY LABORATORY, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY ELECTROPHYSIOLOGY LABORATORY, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOME CARE SETTING, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOME CARE SETTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. CALIFORNIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 29. CALIFORNIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
TABLE 30. CALIFORNIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. CALIFORNIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. FLORIDA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 33. FLORIDA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
TABLE 34. FLORIDA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. FLORIDA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. ILLINOIS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 37. ILLINOIS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
TABLE 38. ILLINOIS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. ILLINOIS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. NEW YORK IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 41. NEW YORK IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
TABLE 42. NEW YORK IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. NEW YORK IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. OHIO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 45. OHIO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
TABLE 46. OHIO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. OHIO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. PENNSYLVANIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 49. PENNSYLVANIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
TABLE 50. PENNSYLVANIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. PENNSYLVANIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. TEXAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 53. TEXAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
TABLE 54. TEXAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. TEXAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 57. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 58. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 59. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 60. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 61. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 62. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET MERGER & ACQUISITION
TABLE 63. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 64. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 65. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET INVESTMENT & FUNDING
TABLE 66. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 67. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • AtaCor Medical, Inc.
  • BIOTRONIK SE & Co KG
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • LivaNova plc
  • Medtronic plc
  • MicroPort Scientific Corporation

Methodology

Loading
LOADING...